These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9288709)

  • 21. [Measles vaccines].
    Janaszek W
    Przegl Epidemiol; 1999; 53(3-4):281-90. PubMed ID: 10800565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.
    Costa A; Henao-Restrepo AM; Marie Hall S; Jarrett S; Hoekstra EJ
    J Infect Dis; 2003 May; 187 Suppl 1():S22-8. PubMed ID: 12721888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe].
    Garcés-Sánchez M; Renales-Toboso M; Bóveda-García M; Díez-Domingo J
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):673-8. PubMed ID: 26611100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress toward measles elimination--region of the Americas, 2002-2003.
    Ann Pharmacother; 2004 Jun; 38(6):1108. PubMed ID: 15122007
    [No Abstract]   [Full Text] [Related]  

  • 25. Global eradication of measles: an epidemiologic and economic evaluation.
    Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased transmission and outbreaks of measles--European Region, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1605-10. PubMed ID: 22129994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles: two US outbreaks are blamed on low vaccination rates.
    Hopkins Tanne J
    BMJ; 2019 Jan; 364():l312. PubMed ID: 30665901
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: "Outbreaks in highly vaccinated populations: implications for studies of vaccine performance".
    Prevots DR; Watson JC; Redd SC; Atkinson WA; Burks-Weathers L; Snyder S; Wainscott B; Finger R
    Am J Epidemiol; 1997 Nov; 146(10):881-2. PubMed ID: 9384208
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of measles control in Kenya, with focus on recent innovations.
    Manakongtreecheep K; Davis R
    Pan Afr Med J; 2017; 27(Suppl 3):15. PubMed ID: 29296150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles vaccination advised before travel to World Cup in Germany, but risk of measles infection low.
    Krause G; Siedler A; Schenkel K; Steffens I
    Euro Surveill; 2006 Jun; 11(6):E060615.5. PubMed ID: 16819126
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005.
    Muller CP; Kremer JR; Best JM; Dourado I; Triki H; Reef S;
    Vaccine; 2007 Jan; 25(1):1-9. PubMed ID: 17262908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. World Conference on Poliomyelitis and Measles: Vaccines and Immunization. 7-12 January 1992, New Delhi, India.
    Kurstak E
    Vaccine; 1993; 11(1):93-5. PubMed ID: 8427041
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the vaccination of a mixture of inactivated and measles vaccines. 2. Investigation on occurrence of measles in Utsunomiya City].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):170-4. PubMed ID: 5065658
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endeavors to eradicate measles in the Americas].
    de Quadros CA
    Rev Esp Salud Publica; 1999; 73(5):589-96. PubMed ID: 10650749
    [No Abstract]   [Full Text] [Related]  

  • 35. [The vaccination in danger?].
    Fischer A
    Med Sci (Paris); 2017 Feb; 33(2):119-120. PubMed ID: 28240197
    [No Abstract]   [Full Text] [Related]  

  • 36. [Measles in Europe: necessity of global and local action to achieve its eradication].
    González-Marrón A; Martínez-Sánchez JM
    Gac Sanit; 2018; 32(6):590-591. PubMed ID: 28928057
    [No Abstract]   [Full Text] [Related]  

  • 37. Measles in Europe in 2001-2002.
    Muscat M; Glismann S; Bang H
    Euro Surveill; 2003 Jun; 8(6):123-9. PubMed ID: 12878801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles and healthcare workers.
    Atkinson WL
    Infect Control Hosp Epidemiol; 1994 Jan; 15(1):5-7. PubMed ID: 8133010
    [No Abstract]   [Full Text] [Related]  

  • 39. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles vaccines used in Japan.
    Hirayama M
    Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.